与免疫检查点抑制剂avelumab相关的肺部不良事件的特征:基于FAERS的药监测研究,从2013年到2024年进行
1Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Journal of chemotherapy (Florence, Italy)
|September 18, 2025
概括
阿维卢马布是一种PD-L1抑制剂,可能会增加严重肺部疾病的风险,如细菌性肺炎和肺炎. 医疗保健提供者应监测患者是否有呼吸系统问题的早期迹象.
科学领域:
- 在瘤学瘤学.
- 肺部病理学 肺部病理学
- 药物监督 药物监督 药物监督
背景情况:
- 免疫疗法,包括像阿维卢马布这样的PD-L1抑制剂,代表了癌症治疗的重大进步.
- 然而,阿维卢马布的肺安全性需要进一步阐明.
研究的目的:
- 调查阿维卢马布使用与呼吸道并发症发生之间的关联.
- 为了确定可能与avelumab相关的特定肺毒性.
主要方法:
- 从2013年到2023年利用了FDA不良事件报告系统 (FAERS) 数据库.
- 使用OpenVigil 2.1进行不成比例分析,以评估avelumab与呼吸系统不良事件之间的关联.
主要成果:
- 在Avelumab和细菌性肺炎 (ROR 6.79),肺炎 (ROR 4.37),呼吸衰竭 (ROR 3.99),肺 (ROR 3.40),呼吸困难 (ROR 3.31) 和肺栓塞 (ROR 2.87) 之间发现了显著的关联.
- 没有发现非特异性肺炎 (ROR 0.97) 或呼吸障碍 (ROR 0.97) 的显著信号.
结论:
- 艾维卢马布可能与特定严重肺毒性的风险增加有关.
- 建议在接受阿维卢马布的患者中对早期呼吸损害进行临床警.
- 需要进一步的前性研究来确定因果关系并制定预防策略.
相关概念视频
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Therapeutic Drug Monitoring: Affecting Factors
202
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
202
Drug Administration and Therapy Phases: Overview
1.3K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.3K
COPD: Pathogenesis and Clinical Features
1.8K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.8K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Factors Affecting Protein-Drug Binding: Patient-Related Factors
305
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
305

